HAI Consultation Response on World Health Organization’s 13th General Programme of Work (GPW13)

Joint Letter to Jeremy Hunt – Environmental Pollution at Pharma Factories

SRH Commodities: Measuring Prices, Availability & Affordability (Methodology & Data Entry Manual)

Recommendations to Strengthen WHO EURO Member State Collaboration on Improving Access to Medicines

Joint Letter to OECD on Sustainable Access to Innovative Therapies

Pharmaceutical Promotion in Medical and Pharmacy Education in The Netherlands: Readiness for Curriculum Change

Scenario 6: Sustainable Europe for Its Citizens

HAI & Global Snakebite Initiative Applaud WHO’s Adoption of Snakebite Envenoming as Top-level Neglected Tropical Disease

Media Release: Health Action International Commend Decision By World Health Organization Not To Include Long-Acting Analogue Insulins On The Essential Medicines List

Joint Letter to Jean-Claude Juncker: EU Health Collaboration is Crucial for Europe’s Future

European Union Leadership Critical for Affordable & Responsible Antibiotic R&D

Response to Health Canada on Release of Clinical Data

Proposed Changes to EMA’s Access to Documents Policy Fall Short on Proactive Disclosure

Joint Response to EMA Consultation on Its Access to Documents Policy

Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices

Response to OECD Online Consultation ‘Sustainable access to innovative therapies’

Statement to the WHO Expert Committee on Selection and Use of Essential Medicines

ACCISS Study Report | Biosimilar Insulin Regulatory Profile

2016 Annual Report & Financial Statements

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines

Conference Report: Clinical Drug Trials

Media Release: European Public Health Advocates Demand Greater Public Returns From European Commission’s Research and Development Programme, Horizon 2020

Joint Submission to European Commission Public Consultation on Horizon 2020

HAI Response to the European Commission’s Consultation about EU Cooperation on Health Technology Assessments

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia and Tanzania